首页|基于网络药理学和细胞学实验探讨黄芩对糖尿病心肌纤维化的保护作用及机制

基于网络药理学和细胞学实验探讨黄芩对糖尿病心肌纤维化的保护作用及机制

扫码查看
[目的]探讨黄芩有效成分在改善糖尿病心肌病(DCM)纤维化中的作用及机制.[方法]通过TC-MSP数据库及小分子药物靶点预测在线平台(Swiss Target Prediction)挖掘黄芩有效成分及所对应的靶点,利用GeneCards、Disgenet、UniProt、OMIM数据库收集并筛选DCM相关的疾病基因靶点,获取交集基因后导入String 11.5数据库中,构建药物-疾病蛋白互作网络图,利用Cytoscape 3.9.1软件对关键靶点网络进行可视化.运用Metascape在线平台挖掘黄芩有效成分抗DCM的分子靶点,并通过KEGG数据库绘制通路图.H9c2和AC16心肌细胞经5.5 mmol/L D-葡萄糖刺激为正常糖对照组,以35 mmol/L D-葡萄糖刺激为高糖组,以10 μmol/L黄芩苷进行干预,采用RT-qPCR检测转化生长因子β1(TGF-β1)、胶原蛋白Ⅰ(COL Ⅰ)和胶原蛋白Ⅲ(COL Ⅲ)的mRNA表达水平,Western blot检测Smad2/3、p-Smad2/3、COL Ⅰ和COL Ⅲ的蛋白表达水平,ELISA测定上清中TGF-β1水平.[结果]通过上述平台共检索得到包括黄芩苷在内的33个有效成分、441个核心靶点和1 884个DCM疾病基因,取交集后得到黄芩治疗DCM的150个核心基因,经String-PPI得到药物疾病基因间相互作用的TGF-β1、TP53、MMP-9及IL-6等基因;KEGG富集到MAPK、PI3K/Akt等信号通路.体外实验显示,高糖刺激H9c2和AC16心肌细胞导致TGF-β1、COL Ⅰ、COL Ⅲ mRNA表达水平、p-Smad2/3、COL Ⅰ、COL Ⅲ蛋白表达水平上调及显著增加上清中TGF-β1含量,黄芩苷显著减弱其表达.[结论]黄芩多活性成分通过多靶点发挥抗DCM作用,其中活性成分黄芩苷通过抑制TGF-β1/Smad信号改善高糖诱导的心肌细胞纤维化而在DCM中发挥保护作用.
Protective effect and mechanism of Scutellariae Radix on fibrosis in diabetic cardio-myopathy based on network pharmacology and cytology experiments
Aim To explore the role and mechanism of the effective ingredients of Scutellariae Radix in improving the fibrosis of diabetes cardiomyopathy(DCM).Methods The technology platform of Chinese medicine system pharmacology(TCMSP)and the small molecule drug target prediction(Swiss Target Prediction)platform were used to excavate the active components of Scutellariae Radix and the target of its response.DCM related disease gene targets were screened using GeneCards,Disgene,UniPort and OMIM databases,and intersecting genes were imported into the String 11.5 database to construct a drug-disease-protein interaction network diagram.Cytoscape 3.9.1 software was a-dopted to visualize the key target network.Metascape platform was used to explore the molecular targets of Scutellariae Radix effective ingredients against DCM,and draw pathway maps through the KEGG database.H9c2 and AC16 cardio-myocytes were stimulated with 5.5 mmol/L D-glucose as the normal glucose control group,35 mmol/L D-glucose as the high glucose group,and 10 µmol/L Baicalin was used for intervention.The levels of TGF-β1,collagen Ⅰ(COL Ⅰ)and collagen Ⅲ(CO LⅢ)mRNA were detected by RT-qPCR,and the expression of Smad2/3,p-Smad2/3,COL Ⅰ and COL Ⅲprotein were detected by Western blot,TGF-β1 level in supernatant was assessed by ELISA.Results Through the a-bove platform,a total of 33 effective ingredients including Baicalin,441 core targets,and 1 884 DCM disease genes were retrieved,150 core genes for treating DCM with Scutellariae Radix were obtained.The drug-disease interacted genes such as TGF-β1,TP53,MMP-9 and IL-6 were obtained through String PPI,KEGG signaling pathways such as MAPK and PI3K/Akt were enriched.In vitro experiments showed high glucose stimulation of H9c2 and AC16 cardiomyocytes led to upregulation of TGF-β1,COL Ⅰ and COL Ⅲ mRNA levels,p-Smad2/3,COL Ⅰ and COL Ⅲ protein levels,and signifi-cantly increased the content of TGF-β1 in the supernatant,while Baicalin weakened its expression.Conclusion The active ingredients of Scutellariae Radix exert anti DCM effects through multiple targets,among which Baicalin inhibits TGF-β1/Smad signaling to improve high glucose induced cardiomyocyte fibrosis and plays a protective role in DCM.

diabetic cardiomyopathynetwork pharmacologyScutellariae Radixcardiomyocytefibrosis

施凯佳、罗才、赵阳阳、朱星霖、柴金萱、郭峻莉、揭伟

展开 >

海南医学院第一附属医院 海南省热带心血管病研究重点实验室,海南省海口市 571199

糖尿病心肌病 网络药理学 黄芩 心肌细胞 纤维化

海南省重点研发项目国家自然科学基金项目

ZDYF2022SHFZ03882060053

2024

中国动脉硬化杂志
中国病理生理学会 南华大学

中国动脉硬化杂志

CSTPCD
影响因子:1.086
ISSN:1007-3949
年,卷(期):2024.32(5)